1,1-Dioxothiomorpholine-4-sulfonamide → HCID 59558782、化合物
反応式
[O:1]=[S:2]1(=[O:12])[CH2:7][CH2:6][N:5]([S:8]([NH2:11])(=[O:10])=[O:9])[CH2:4][CH2:3]1.Cl[C:14]1[CH:19]=[C:18]([O:20][CH3:21])[N:17]=[C:16]([S:22][CH2:23][C:24]2[CH:29]=[CH:28][CH:27]=[C:26]([F:30])[C:25]=2[F:31])[N:15]=1>>[F:31][C:25]1[C:26]([F:30])=[CH:27][CH:28]=[CH:29][C:24]=1[CH2:23][S:22][C:16]1[N:15]=[C:14]([NH:11][S:8]([N:5]2[CH2:4][CH2:3][S:2](=[O:1])(=[O:12])[CH2:7][CH2:6]2)(=[O:9])=[O:10])[CH:19]=[C:18]([O:20][CH3:21])[N:17]=1参加物
3
実験手順
The title compound was prepared from 1,1-dioxothiomorpholine-4-sulfonamide (0.31 g, McManus, J. M. et al, J. Med. Chem (1965) 8 766-776) and 4-chloro-2-[[(2,3-difluorophenyl) methyl]thio]-6-methoxypyrimidine (the product of Example 35, step i) (0.25 g) according to the procedure outlined in Example 1, step iv). The crude material was purified by column chromatography using EtOAc/isohexane (1:1) as eluent. Yield: 0.48 g
後処理
- customThe crude material was purified by column chromatography
出典と根拠
- ORDレコード
- ord-1293993be75143e297a5f47fbdd9ef0e
- 出典データセット
- uspto-grants-2014_05
- 特許番号
- US08722883B2
反応ノート
読み込み中…